Lan et al. show that a subset of CD9hi tumor-initiating cells in pancreatic cancer exhibits hybrid-EMT features and possesses enhanced self-renewal and differentiation capacities. Depletion of these cells or blockage of Jagged1-Notch signaling impairs tumorigenesis and cellular heterogeneity, revealing a vulnerability for pancreatic cancer.